| Nov 21 |
Investors Could Be Concerned With Rogers' (NYSE:ROG) Returns On Capital
|
| Nov 18 |
Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE
|
| Nov 1 |
Rogers' (NYSE:ROG) Shareholders Have More To Worry About Than Only Soft Earnings
|
| Oct 26 |
Rogers Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Oct 25 |
Q3 2024 Rogers Corp Earnings Call
|
| Oct 25 |
Rogers Corp (ROG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
|
| Oct 25 |
Rogers Corporation (ROG) Q3 2024 Earnings Call Transcript
|
| Oct 24 |
Rogers Corporation 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 24 |
Rogers Corp. (ROG) Surpasses Q3 Earnings Estimates
|
| Oct 24 |
Rogers Non-GAAP EPS of $0.98 beats by $0.13, revenue of $210.3M misses by $9.8M
|
